Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on June 18, 2026

Jun. 18, 2026

JuneX Capital Partners and New End Associates Back AENDRE's Inaugural Hospitality Acquisition Through GP Seeding and GP Capital Solutions

Indeterminate GlobeNewswire

Jun. 18, 2026

Rixos Opens Second Resort in Hurghada Amid Rising Polish Demand

Indeterminate GlobeNewswire

Jun. 18, 2026

Rixos otwiera drugi resort w Hurghadzie w odpowiedzi na rosnące zainteresowanie Egiptem wśród polskich turystów

Indeterminate GlobeNewswire

Jun. 18, 2026

Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

Indeterminate GlobeNewswire

Jun. 18, 2026

Memo Therapeutics AG Presents Complete Phase II Clinical Trial Data for Potravitug in Kidney Transplant Recipients at the American Transplant Congress 2026

Indeterminate GlobeNewswire

Jun. 18, 2026

Essential Pharma appoints Becki Morison as Chief Executive Officer

Indeterminate GlobeNewswire

Jun. 18, 2026

VERAXA Biotech Establishes in vitro Proof-of-Concept for Novel BiTAC-ADC Technology Platform and Launches Partnering Discussions at BIO International Convention 2026

Indeterminate GlobeNewswire

Jun. 18, 2026

Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”

Indeterminate GlobeNewswire

Jun. 18, 2026

Grey Matters Announces Increase to Private Placement Financing to $1.25 Million and Closing of Offering

Indeterminate GlobeNewswire

Jun. 18, 2026

Hi*Ball Energy Arrives in the UK, Leading a New Wave of Clean Energy

Indeterminate GlobeNewswire

Jun. 18, 2026

Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness Month

Indeterminate GlobeNewswire

Jun. 18, 2026

Asimov Announces Strategic Partnership with the Rosalind & Morris Goodman Cancer Institute at McGill University to Advance Next-Generation Biologics

Indeterminate GlobeNewswire

Jun. 18, 2026

CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia with Lewy Body Patients into 2042

Indeterminate GlobeNewswire

Jun. 18, 2026

Alturos Therapeutics advancement of lead candidate ALT0135, a potentially first-in-class, orally bioavailable small molecule, into IND-enabling studies

Indeterminate GlobeNewswire

Jun. 18, 2026

Deepening China-Norway Services Trade Cooperation: Promotion Event for Norway as the Guest Country of Honor at CIFTIS 2026 Held in Beijing

Indeterminate GlobeNewswire

Jun. 18, 2026

Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement

Indeterminate GlobeNewswire

Jun. 18, 2026

New analyses from FIBRONEER™ trials suggest survival benefit with nerandomilast in IPF and PPF

Indeterminate GlobeNewswire

Jun. 18, 2026

Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares

Indeterminate GlobeNewswire

Jun. 18, 2026

BIO-Europe unveils renewed vision as the must-attend global biopharma strategy forum

Indeterminate GlobeNewswire

Jun. 18, 2026

Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470

Indeterminate GlobeNewswire